» Articles » PMID: 16809167

Do Needle Syringe Programs Reduce HIV Infection Among Injecting Drug Users: a Comprehensive Review of the International Evidence

Overview
Publisher Informa Healthcare
Date 2006 Jul 1
PMID 16809167
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

This first international review of the evidence that needle syringe programs reduce HIV infection among injecting drug users found that conservative interpretation of the published data fulfills six of the nine Bradford Hill criteria (strength of association, replication of findings, temporal sequence, biological plausibility, coherence of evidence, and reasoning by analogy) and all six additional criteria (cost-effectiveness, absence of negative consequences, feasibility of implementation, expansion and coverage, unanticipated benefits, and application to special populations). The Bradford Hill criteria are often used to evaluate public health interventions. The principal finding of this review was that there is compelling evidence of effectiveness, safety, and cost-effectiveness, consistent with seven previous reviews conducted by or on behalf of U.S. government agencies. Authorities in countries affected or threatened by HIV infection among injecting drug users should carefully consider this convincing evidence now available for needle syringe programs with a view to establishing or expanding needle syringe programs to scale.

Citing Articles

Correction: Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts' Merrimack Valley: Highlights from a Case Study.

Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S AIDS Behav. 2024; 29(2):584-588.

PMID: 39676088 PMC: 11813815. DOI: 10.1007/s10461-024-04567-w.


Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts' Merrimack Valley: Highlights from a Case Study.

Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S AIDS Behav. 2024; 29(2):562-583.

PMID: 39511061 PMC: 11813996. DOI: 10.1007/s10461-024-04540-7.


Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes.

Akiba C, Smith J, Wenger L, Morris T, Patel S, Bluthenthal R SSM Qual Res Health. 2024; 5.

PMID: 38957482 PMC: 11218888. DOI: 10.1016/j.ssmqr.2024.100421.


"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.

Walker S, Curtis M, Kirwan A, Thatcher R, Dietze P Harm Reduct J. 2024; 21(1):51.

PMID: 38402389 PMC: 10894474. DOI: 10.1186/s12954-024-00960-9.


Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital.

Brooks H, Speed K, Dong K, Salvalaggio G, Pauly B, Taylor M PLoS One. 2024; 19(2):e0297584.

PMID: 38359010 PMC: 10868849. DOI: 10.1371/journal.pone.0297584.